MCC Update 04-15-14
Update is an official newsletter of the Masonic Cancer Center for faculty, members, staff, colleagues, and friends. All submissions for the next issue must be sent to Sandi Sherman, email@example.com, by Noon on the Fridays for publication the following Tuesday.
April 15, 2014
Tuesday, April 15, 2014, 1-125 CCRB
RPN13 as a target for cancer therapy
Richard Roden, Ph.D., Associate Professor, Department of Pathology, Johns Hopkins University
Hosted by the Gynecologic Oncology Translational Working Group
Seminar will be simulcast to 450 MCRB. Shuttles to CCRB are also available and may be boarded in front of Variety Club Heart Clinic on E. River Parkway. See website for details on pick-up time. See website for details on pick-up time.
A peek at the next seminar:
Tuesday, April 22, 2014, 12-1 p.m., 1-125 CCRB
Inflammatory and immune response and the development of colorectal cancer
Anna Prizment, Ph.D., M.P.H.. Assistant Professor, Division of Epidemiology and Community Health, School of Public Health, University of Minnesota
Members in the news
Fox 9 highlighted the story of a woman battling pancreatic cancer. The segment featured Ashok Saluja, Ph.D., and Edward Greeno, M.D., discussing the Minnelide treatment being developed at the U of M.
Todd Tuttle, M.D., was quoted in a National Public Radio Shots: Health News From NPR story about the growing number of women choosing double mastectomies after a breast cancer diagnosis. Read more.
Michael Garwood, Ph.D., Tumor Microenvironment Program, discussed the role of magnetic nanoparticles in breast cancer treatment in a Nanowerk News story.
Congratulations to Anindya Bagchi, Ph.D., Genetic Mechanisms of Cancer Program, who was recently selected an American Cancer Society Research Scholar, for his project “Functional analysis of low copy number gain of human 8q24 in breast cancer.” This-four year $792,000 grant provides research funds of $165,000 a year for this project.
Tumor Microenvironment Program
Tuesday, April 15, 1:30-2:30 p.m., 3-150 CCRB
Jill Siegfried, Ph.D., Chair, Department of Pharmacology and associate director of translational research, will present her research on lung cancer.
April 16, 2014: Cancer Biology Journal Club
12-1 p.m., 2-115 CCRB
Tarah Regan Anderson, Lange lab, will discuss "XBP1 promotes triple-negative breast cancer by controlling the HIF1α pathway," Chen X et al., Nature 2014;508:103-107.
April 18, 2014: Division of Epidemiology & Community Health Seminar
10-11 a.m., 364 WBOB, 1300 South 2nd Street, 3rd floor
Research in HIV, HPV, and cervical cancer in Senegal
Stephen Hawes, Ph.D., M.S., Associate Professor, Department of Epidemiology, Adjunct Associate Professor, Departments of Health Services and Global Health, School of Public Health, University of Washington
April 27-30, 2014: International Conference on One Medicine One Science
The Commons Hotel, 615 Washington Ave. SE, Minneapolis, MN 55414
Hosted by the University of Minnesota College of Veterinary Medicine, Academic Health Center and the Office of the Vice President for Research in partnership with allied national and international agencies. For more information visit the website.
May 6-7, 2014: Distinguished Visiting Scholar Series on Health Disparities
Collins Airhihenbuwa, Ph.D., M.P.H., Director, Global Health and Culture Project, Department of Behavioral Health, Pennsylvania State University
May 6, 2014: Community Dialogue with Dr. Airhihenbuwa
2:30 p.m., location to be announced
May 7, 2014: Culture, Race, and Research: Negotiating the Journey Between the Head and the Heart
11:45 a.m.-1:05 p.m., Mayo Auditorium
Visit the Education and Training Opportunities web page for more conference and special lecture listings.
April 18, 2014: Help Launch Kill Kancer
7 p.m., Cedar Cultural Center, 416 Cedar Ave S, Minneapolis
Fundraising event for cancer research at the University of Minnesota featuring Dave Pirner, Silverback Colony, Communist Daughter, Willie Murphy and special guests Taj Raj. For ticket information visit the website. For more information about Kill Cancer visit their website.
May 9, 2014: Hippocrates Cafe: The Sarcoma Journey
6:30 p.m., Mill City Clinic, 901 S. Second St., Suite A, Minneapolis, MN 55415; $20 per person
Join us for an evening, May 9, 2014 at 6:30 p.m., when Hippocrates Cafe productions use professional actors and musicians to explore complex healthcare topics. The Sarcoma Stories performance and exhibit will explore the human side of being a sarcoma patient, family member, friend or healthcare giver.
Creator and producer of Hippocrates Cafe, Dr. Hallberg is an assistant professor in family medicine at the University of Minnesota, medical director at Mill City Clinic and a medical commentator for Minnesota Public Radio. Registration is limited to 100 participants. To register visit the website.
May 17, 2014: Register today! Cancer Survivorship Series
8 a.m.-1 p.m., McNamara Alumni Center, University of Minnesota, 200 Oak Street, SE, Minneapolis, MN 55455
The 2014 Cancer Survivorship Conference will focus on questions and issues survivors and their families often face after cancer treatment or following stem-cell transplantation. The emphasis is on educating and empowering survivors so they are better able to advocate for themselves and lead full and productive lives. Join us for this educational conference which will focus on exercise and wellness for the cancer survivor. Read more.
Visit the Community Events and Outreach page for more information.
Masonic Cancer Center Women’s Health Scholar – Request for Applications
Sponsor: Powell Center for Women’s Health/Masonic Cancer Center
Deadline: May 15, 2014
Funding: 75% of salary support (up to $100,000 inclusive of fringe), $25,000 research support
- One position is available starting on or after September 1, 2014.
- Assistant Professor (in rank ≤ 6 years)
- Scholar will participate in all aspects of the Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) K12 training program.
- Start date to be determined and will be on or after September 1, 2014.
- Scholars may apply by submitting a one-page addendum (see attachment for details) to the CTSA KL2 RFA by May 15, 2014. If this additional page is submitted, you will be considered for both the KL2 program and the Masonic Cancer Center Women’s Health Scholarship.
The BIRCWH program is an internal K12 grant mechanism from the National Institutes of Health (NIH) Office of Research on Women’s Health that fosters mentored research career development of junior faculty who are engaged in interdisciplinary basic, translational, behavioral, clinical, and/or health services relevant to women’s health or sex differences research.
The Masonic Cancer Center Women’s Health scholar is funded through the UMN Masonic Cancer Center to support one researcher whose work focuses on cancers that occur mainly in women or is exploring important gender differences in cancer incidence, presentation, survivorship, treatment, and pathology.
The aim of this training program is to place junior investigators on the path to be competitive for NIH independent K- or R- awards. One Masonic Cancer Center Women’s Health scholar will be funded during this cycle. Success of this program will be judged by the number of trainees who go on to secure NIH independent K-awards and NIH R21 grants in the short term, and NIH R01, and R01 equivalent funding in the long term, for women’s health or sex differences research.
If you have additional questions, contact the Powell Center for Women’s Health at 612-626-1125 or firstname.lastname@example.org.
Stand Up To Cancer (SU2C)-Cancer Research UK Translational Research Fellowships
Deadline: July 28, 2014
Funding: Up to $315,000
The Stand Up To Cancer (SU2C)-Cancer Research UK Translational Research Fellowships will provide up to four grants for postdoctoral or clinical research fellows, each up to $315,000, over a four-year period. This opportunity, provided by SU2C and Cancer Research UK, is the first joint research project resulting from the collaboration between the two groups announced in 2012. Fellowship support will be provided to talented and promising early-career investigators in the United States and the United Kingdom who demonstrate clear potential to become leaders in their fields. Research projects must be translational in nature and address critical problems in cancer with the potential to deliver benefit to patients.
The proposed work must be performed in two phases, one in the United States and one in the United Kingdom. Each phase must be one to three years in length; the total support period is a maximum of four years. Applications must identify one mentor and host laboratory in the United States and one mentor and host laboratory in the United Kingdom. Mentors should be established leaders in cancer research with a track record of successful mentoring. The research proposal must describe how the work has the potential to advance to the clinic.
Visit the Funding Opportunities Web page to see listings previously published in Update. A list of organizations that provide funding for cancer research is also provided there.